NCT04406831View on ClinicalTrials.gov

The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer

RecruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2027

Conditions

Pancreatic Cancer Stage IIIPancreatic Cancer Stage IVPancreatic Ductal AdenocarcinomaPancreatic Neoplasms

Interventions

PROCEDURE

Blood draw

Individuals in the unresectable pancreatic cancer group will receive monthly blood draws. Individuals in the control group will receive one blood draw

Trial Locations (1)

06856

RECRUITING

Nuvance Health, Norwalk